ABSA International
ABSA International

Resources with keywords: Monkeypox



Ocular Monkeypox — United States, July–September 2022
CDC/MMWR
17 October 2022

Cash-Goldwasser S, Labuda SM, McCormick DW, et al.

keywords: Monkeypox, ocular
Monkeypox Case Investigation — Cook County Jail, Chicago, Illinois, July–August 2022
CDC/MMWR
7 October 2022

Hagan LM, Beeson A, Hughes S, et al.

Nation’s first MPX case in healthcare worker exposed on the job is reported in L.A. County
Los Angeles Times
Monkeypox DNA levels correlate with virus infectivity in clinical samples, Israel, 2022
Eurosurveillance

Paran N, et al.
 In this study, the authors test for a correlation between MPXV DNA copies in patient specimens.

Monkeypox: UKHSA laboratory assessments of inactivation methods
Gov.uk - UKHSA

Multiple protocols for inactivation of MPX are included in this resource, for example, Buffer AVL, 70% ethanol, L6 Buffer and others

Risk communication and community engagement (RCCE) for monkeypox outbreaks: Interim guidance, 24 June 2022
WHO
Notice of Enforcement Discretion Regarding Monkeypox Medical Waste
DOT

Discusses handling of medical waste based on whether testing indicates it is from the West African clade (Cat. B) or the Congo Basin clade (Cat. A)

Monkeypox Update: FDA Authorizes Emergency Use of JYNNEOS Vaccine to Increase Vaccine Supply
FDA

For individuals 18 years of age and older determined to be at high risk of monkeypox infection, the EUA now allows for a fraction of the JYNNEOS dose to be administered between the layers of the skin (intradermally).

08/23/2022: Lab Advisory: Monkeypox Virus Testing Considerations to Prevent False Positive Test Results
CDC/Laboratory Outreach Communication System (LOCS)

Worldwide, there have been no reports of transmission of monkeypox virus through blood transfusion and the risk of transfusion-transmission remains theoretical.

Information for Blood Establishments Regarding the Monkeypox Virus and Blood Donation
FDA
Go to Top